Regenerative Medicine Catalyst Grants 2025
Supports innovative research in regenerative medicine across cell therapy, disease modeling, biomaterials, and clinical translation, aiming to advance new therapies and foster Nordic and international collaboration.
Funder: Novo Nordisk Foundation
Due Dates (Anticipated): September 2026 (Phase I concept note) | December 2026 (Phase II full application)
Funding Amounts: Up to DKK 5 million for standard projects; up to DKK 10 million for collaborative projects; project duration up to 3 years
Summary: Supports innovative translational research in regenerative medicine, fostering Nordic and international collaboration to advance new therapies and scientific breakthroughs.
Key Information: Two-phase application: concept note (Phase I), then full proposal (Phase II, by invitation only).
Description
This grant supports research leaders in bioscience, basic biomedicine, and clinical/translational medicine to catalyze innovative projects in regenerative medicine. The program aims to advance foundational and translational research that can lead to new therapies, strengthen the Nordic regenerative medicine ecosystem, and promote international collaboration. Projects must address at least one of four thematic areas: challenges in autologous/allogeneic cell therapy, stem cell-based disease modeling, engineering biomaterials for regenerative therapy, or transitioning cell therapies from academia to clinical development. Projects focused on immune cell-based or gene therapies are not prioritized.
